Top 10 Quality Companies To Invest In 2014

It�� countdown time for Bed Bath & Beyond (BBBY) and we wonder: will another retailer bite the dust (bin)?

Bloomberg

It wouldn’t be much of a shock. In an article earlier today, MarketWatch reporter Andria Cheng notes that industry rivals including Pier 1 Imports (PIR), the Container Store (TCS) and Williams-Sonoma (WSM) lowered their profit or sales outlooks. Cheng also notes that Bed Bach & Beyond had cut its outlook in June to $1.08 a share from $1.16. She continues:

Morgan Stanley�� home-furnishings survey conducted in August and released Monday found almost 80% of shoppers at Bed Bath & Beyond in the past three months listed the company�� 20% off an-item coupon as what drove them to the store, much higher than other factors including selection or quality of merchandise

What does that mean for Bed Bath & Beyond, which will release its financial results after the close today? Nomura�� Jessica Schoen Mace doesn’t think Bed Bath & Beyond will beat the Street Consensus–she forecasts earnings-per-share of $1.13, a penny below the average analyst prediction–but she’s not completely down on the company. Schoen Mace writes:

Top Undervalued Stocks To Invest In 2015: MCG Capital Corporation(MCGC)

MCG Capital Corporation is a private equity firm specializing in investments in middle market companies. The firm does not prefer investments in highly cyclical and volatile industry sectors and businesses with significant volatility exposure. It seeks to invest in small to mid sized companies. The firm prefers to invest in acquisitions, growth financings, organic growth, recapitalization, and leveraged buyouts. It invests in companies based in the United States. The firm seeks to invest upto $75 million in debt and equity in companies having revenues between $20 million and $200 million and EBITDA between $3 million and $25 million. It seeks to invest in the form of senior debt, including amortizing, bullet maturity, term loans, and revolving credit facilities; institutional sub debt, including junior capital; second lien debt, that includes term loans on sole source and participant basis; secured and unsecured subordinate loans structured as current interest, deferred in terest, and equity linked components; mezzanine debt and equity that includes minority equity investments. The firm may invest in minority or control equity positions. It was formerly known as MCG Credit Corporation. MCG Capital Corporation was founded in 1990 and is based in Arlington, Virginia.

Advisors' Opinion:

• [By Equities Lab]

  The stocks that currently pass the stock screen in order of market cap are Frontier Communications Corp , Crown Media Holdings (CRWN), Vonage Holding (VG), MCG Capital Corp (MCGC), 1-800-FLOWERS.COM (FLWS), MTR Gaming Corporation (MNTG), Alaska Communications (ALSK), and Enzon Pharmaceuticals (ENZN).

Top 10 Quality Companies To Invest In 2014: Nexans SA (NEX)

Nexans SA is a French company engaged in the cable industry. It provides copper and fiber-optic cables and cabling systems to the Energy Infrastructure, Industry, Building and Local Area Network (LAN) markets. It operates under three segments: Energy, Telecom and Electrical Wires and has six main product lines: indoor cabling, which includes rugged industrial, fire-performance and standard domestic cables; industrial cabling, which comprises a variety of cables for the automotive, aerospace and defense industries, among others; power network cabling, which offers low, medium and high-voltage cables; telecom network cabling that includes a range of copper and optical fiber cables and associated interconnect solutions and cable maker supply, which includes the provision of conductors and superconductive materials for making cables. The LAN Segment provides cables for business networks and offers integrated solutions combining cables, connectors, administration and security. Advisors' Opinion:

• [By Michael Lewis]

  Bloomberg via Getty Images William 'Bill' Ackman founder and CEO of Pershing Square Capital Management (left) Daniel Loeb, founder and CEO of Third Point: Two activist investors taking big positions in large public companies and demand even bigger changes. Is activist investing a force for good when it comes to shareholders? Recent events, namely the Bill Ackman-J.C. Penney (JCP) debacle, have left investors and analysts tired of the outspoken hedge-funders of the world. There are, of course, plenty of activists whose actions have enhanced not just their funds' portfolios, but those of passive, minority shareholders. They've forced companies to make positive changes -- to restructure, elect new board members, and get back on track toward healthier operations. Then again, others end up like J.C. Penney -- a seemingly lost business, rich with legacy yet left crippled by boardroom drama. That leaves us -- the average consumers and investors -- with a pressing question: Are these megaphoned power players trying to effect change that will benefit all, the company included? Or are they just after results that will juice their own returns? The Age of Activism While many activist investors consider themselves to be molded in the image of a certain Omaha-based super-investor, many of today's hedge fund superstars have taken a very different approach to the craft of identifying mispriced securities. Like the old guard -- raiders like Carl Icahn and Nelson Peltz -- young guns such as Daniel Loeb and Bill Ackman take substantial positions in large public companies and demand change in an approach that is about as far from Warren Buffett's investor behavior as one can get. Their style can be best described as personality-driven activism. The practice is on the rise, too. According to FactSet, 2012 saw 21 activist campaigns in companies with market caps larger than $1 billion. In 2010, the number was 11. In 2003, there were four. While some passive shareholders may

Top 10 Quality Companies To Invest In 2014: TAL International Group Inc.(TAL)

TAL International Group, Inc. engages in the lease of intermodal containers and chassis. It operates in two segments, Equipment Leasing and Equipment Trading. The Equipment Leasing segment involves in the acquisition, lease, re-lease, and sale of various intermodal transportation equipment, such as dry freight containers, which are used for general cargo, including manufactured component parts, consumer staples, electronics, and apparel; refrigerated containers that are used for perishable items, such as fresh and frozen foods; and special containers, which are used for heavy and oversized cargo, such as marble slabs, building products, and machinery. It also leases chassis, which are used for the transportation of containers and tank containers that are used to transport bulk liquid products, such as chemicals, as well as finances port equipment, which includes container cranes, reach stackers, and other related equipment. The Equipment Trading segment purchases container s from shipping line customers and other sellers of containers, and resells these containers to container traders and users of containers for storage or one-way shipment. As of December 31, 2009, it had a fleet of 701,946 containers and chassis, including 31,137 containers under management for third parties, representing 1,139,523 twenty-foot equivalent units (TEU). The company was founded in 1963 and is headquartered in Purchase, New York.

Advisors' Opinion:

• [By ABN]

  TAL International Group (TAL) is one of the world's largest lessors of intermodal freight containers for the shipping business with 17 offices in 11 countries and approximately 230 third-party container depot facilities in 40 countries. TAL's fleet consists of approximately 1,238,000 containers and 2,031,000 twenty-foot equivalent units (TEU).

• [By Seth Jayson]

  Margins matter. The more TAL International Group (NYSE: TAL  ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong TAL International Group's competitive position could be.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, freight container lessor TAL International (NYSE: TAL  ) has earned a coveted five-star ranking.

• [By Jake L'Ecuyer]

  Among the financial stocks, Zillow (NASDAQ: Z) was down 9.6%, while TAL International Group (NYSE: TAL) tumbled around 3.55%. Shares of TAL International dipped after the company reported downbeat quarterly earnings.

Top 10 Quality Companies To Invest In 2014: bluebird bio Inc (BLUE)

bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. Gene therapy seeks to introduce a functional copy of the defective gene into a patient�� own cells, a process called gene transfer. Through gene transfer, a functional copy of the mutated gene is delivered to the patient�� cells, thereby correcting the underlying genetic defect that causes aberrant gene expression. As of December 31, 2012, the Company is conducting a Phase I/II clinical study in France evaluating an earlier generation of its LentiGlobin vector for the treatment of �-thalassemia major and SCD. Initial proof-of-concept data from this study were published in Nature. During the year ended December 31, 2013, the Company plans to initiate an extension of this study under a revised protocol for LentiGlobin, which the Company refers to as the HGB-205 Study. The Company also plans o initiate a second Phase I/II clinical program in the United States for LentiGlobin, which the Company refers to as the HGB-204 Study, for �-thalassemia major. In March 2013, the Company entered into a strategic collaboration with Celgene Corporation, or Celgene, to discover, develop and commercialize, disease-altering gene therapies in oncology.

Its gene therapy platform is based on viral vectors that utilize a modified, non-replicating version of the Human Immunodeficiency Virus Type 1 (HIV-1) virus, that has been stripped of all of the components required for it to self-replicate and infect additional cells. The HIV-1 virus is part of the lentivirus family of viruses, as a result of which the Company refer to its vectors as lentiviral vectors. Its lentiviral vectors are used to introduce a functional copy of a gene to the patient�� own isolated blood stem cells, called hematopoietic stem cells (HSCs), which reside in a patient�� bone marrow and are capable of differentiating int! o a wide range of cell types. HSCs are dividing cells, thus its approach allows for sustained expression of the modified gene as the Company is able to take advantage of a lifetime of replication of the gene-modified HSCs. Additionally, the Company has developed a cell-based vector manufacturing process that is both reproducible and scalable.

Adrenoleukodystrophy

Adrenoleukodystrophy is a rare X-linked, inherited, neurological disorder that is often fatal. ALD is caused by mutations in the ABCD1 gene which encodes for a protein called the ALD protein (ALDP), which plays a critical role in the breakdown and metabolism of long-chain fatty acids (VLCFA). Without functional ALDP, VLCFA accumulate in cells including neural cells in which they cause damage to the myelin sheath, a protective and insulating membrane that surrounds nerve cells in the brain. This damage can result in decreased motor coordination and function, visual and hearing disturbances, the loss of cognitive function, dementia, seizures, adrenal dysfunction and other complications, including death. ALD is divided into various sub-segments with three main phenotypes that impact brain function: CCALD (Childhood cerebral adrenoleukodystrophy, AMN (Adrenomyeloneuropathy) and ACALD (Adult Cerebral ALD).

�-thalassemia

�-thalassemia is a rare hereditary blood disorder caused by a genetic abnormality of the �-globin gene resulting in defective red blood cells (RBCs). Genetic mutations cause the absence or reduced production of the beta chains of hemoglobin, or �-globin, thereby preventing the proper formation of hemoglobin A, which normally accounts for greater than 95% of the hemoglobin in the blood of adults. Hemoglobin is an iron-containing protein in the blood that carries oxygen from the respiratory organs to the rest of the body. Hemoglobin A consists of four chains-two chains each of a-globin and �-globin. Normally existing at an approximate 1:1 ratio, genetic mutations that impair t! he produc! tion of �-globin can lead to a relative excess of a-globin, premature death of red blood cells. The clinical implications of the a-globin/�-globin imbalance are two-fold: first, patients lack sufficient RBCs and hemoglobin to effectively transport oxygen throughout the body and can become severely anemic; and second, the shortened life span and ineffective production of RBCs can lead to other complications such as splenomegaly, marrow expansion, bone deformities, and iron overload in organs.

Sickle cell disease

Sickle cell disease (SCD) is a hereditary blood disorder resulting from a mutation in the �-globin gene that causes polymerization of hemoglobin proteins and abnormal red blood cell function. The disease is characterized by anemia, vaso-occlusive pain crisis (a common complication of SCD in which there is severe pain due to obstructed blood flow in the bones, joints, lungs, liver, spleen, kidney, eye, or central nervous system), infections, stroke, overall poor life and early death in a subset of patients. Under low-oxygen conditions, which are exacerbated by the red blood cell abnormalities, the mutant hemoglobin aggregates causing the RBCs to take on a sickle shape (sickle cells), which causes them to aggregate and obstruct small blood vessels, thereby restricting blood flow to organs resulting in pain, cell death and organ damage. If oxygen levels are restored, the hemoglobin can disaggregate and the RBCs return to their normal shape, but over time, the sickling damages the cell membrane and the cells fail to return to the normal shape even in high-oxygen conditions.

Advisors' Opinion:

• [By Garrett Cook]

  Bluebird Bio (NASDAQ: BLUE) shares shot up 34.74 percent to $35.15 following the presentation of positive data on LentiGlobin BB305 at the European Hematology Association (EHA).

• [By Garrett Cook]

  Bluebird Bio (NASDAQ: BLUE) shares shot up 33.61 percent to $34.86 following the presentation of positive data on LentiGlobin BB305 at the European Hematology Association (EHA).

Top 10 Quality Companies To Invest In 2014: Reliv' International Inc.(RELV)

Reliv? International, Inc. develops, manufactures, and markets nutritional supplements. Its basic nutrition supplements include Reliv Classic and Reliv NOW, a blend of vitamins, minerals, proteins, and herbs; NOW for Kids, which provides a balanced nutritional supplement for a child?s diet; and Reliv Delight, a powdered nutritional supplement marketed as a milk replacement. The company?s specific wellness supplements comprise ReversAge, a nutritional supplement to slow down the effects of the aging process; SoySentials for use by women; CardioSentials that promotes heart health; Arthaffect, which supports healthy joint function; FibRestore that contains fiber, vitamins, minerals, and herbs; GlucAffect, which assists in healthy blood sugar management and support weight loss; and 24K, a ready-to-drink nutritional supplement that enhances the body?s natural vitality. Its weight management supplements consist of Slimplicity meal replacement and accelerator capsules; Reliv Ultrim-Plus, a meal replacement product; and Cellebrate, a weight loss aid. The company?s sports nutrition supplements include Innergize!, a sports supplement containing vitamins and minerals for performance enhancement; and ProVantage to enhance muscle recovery, muscle mass, and function, as well as to reduce fatigue and burn excess body fat for extra energy. It also offers Relivables product line, which comprises skin care products, marketed as the ?r? skin care collection, as well as food products, such as Relivables All-Natural Sweetener, Relivables Fortified Soy Milk, Relivables Soy Nuts, and Relivables Healthy Snack Bars. Reliv? International markets and sells its products through a network of independent distributors in the United States, Australia, Austria, Brunei, Canada, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. The company was founded in 1984 and is headquartered in Chesterf ield, Missouri.

Advisors' Opinion:

• [By John Udovich]

  Last Friday, small cap dieting stock Weight Watchers International, Inc (NYSE: WTW) lost weight for investors when shares tumbled�27.73% to $22.10, meaning its probabaly a good idea to take a closer look�at the stock along with�other small cap weight loss or dieting stocks like NutriSystem Inc (NASDAQ: NTRI), Medifast Inc (NYSE: MED) and Reliv International, Inc (NASDAQ: RELV). Why did Weight Watchers International loose weight last Friday? The company reported its fourth straight quarterly sales decline as fewer people attended meetings and bought its products and also projected earnings that trailed analysts' estimates with the blame being placed on new mobile applications and bracelets that track calories���thus�hurting traditional diet companies.

Top 10 Quality Companies To Invest In 2014: Vanguard Intermediate Term Bond ETF (BIV)

Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximate the full Index in terms of key risk factors and other characteristics. All of the Fund�� investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund�� investment advisor is The Vanguard Group, Inc. Advisors' Opinion:

• [By GURUFOCUS]

  In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
  Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
  - Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
  - Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
  - Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%

Top 10 Quality Companies To Invest In 2014: AutoNavi Holdings Limited(AMAP)

AutoNavi Holdings Limited provides digital map content, and navigation and location-based solutions in the People?s Republic of China (PRC). The company offers digital map data to various automobile manufacturers for in-dash navigation systems; and navigation solutions for use in in-dash navigation system to portable navigation device manufacturers based on their specific needs, which range from digital map data only to a digital map data, a navigation engine, and an user interface. It provides mobile/Internet location-based solutions to a mobile operator; mobile and Internet-based map application solutions that allow Web sites to embed location-based services capabilities into their Internet and enterprise applications; and MiniMap, an user-end map application software. The company also offers aerial digital maps and 3-D modeling applications to certain PRC government agencies and enterprises to meet their land usage survey, specific needs for 3-D geographic information, and other needs pursuant to a service contract arrangement. In addition, it has collaboration with certain mobile phone and tablet computer manufacturers and mobile operators to pre-install its navigation solutions. The company is headquartered in Beijing, China.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  AutoNavi Holdings (NASDAQ: AMAP) shot up 24.18 percent to $20.54 on Alibaba $21.00 per ADS offer.

  Shares of MannKind (NASDAQ: MNKD) were up as well, gaining 5.75 percent to $5.70 despite little news on the name during Monday's session.